MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis

Patients with multiple sclerosis (MS) should be vaccinated against COVID-19. All COVID-19 vaccines are effective and do not appear to carry any additional risk for patients with MS. Patients with MS should get a COVID-19 vaccine as soon as it becomes available. The risks of COVID-19 disease outweigh...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamout, Bassem I, Zakaria, Magd, Inshasi, Jihad, Al-Jumah, Mohammad, Zeineddine, Maya, Dahdaleh, Maurice, Bohlega, Saeed, Gouider, Riadh, Alroughani, Raed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386106/
https://www.ncbi.nlm.nih.gov/pubmed/34479111
http://dx.doi.org/10.1016/j.msard.2021.103225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386106/
https://www.ncbi.nlm.nih.gov/pubmed/34479111
http://dx.doi.org/10.1016/j.msard.2021.103225

Ejemplares similares